Launch of UNITE4TB partnership marks a new era in tuberculosis treatment development

(Critical Path Institute (C-Path)) To advance anti-tuberculosis (TB) science and enable the progression of new, safe, and affordable treatment solutions for TB patients worldwide, a new consortium of 30 partners from 13 countries has officially launched. The 7-year, € 185 million project called UNITE4TB, aims to accelerate and improve the clinical evaluation of combinations of existing and novel drugs, with the goal of developing new and highly active TB treatment regimens for drug-resistant and -sensitive TB.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news